Global Ophthalmic Viscoelastic Device (OVD) Market Size By Type (Cohesive Ophthalmic Viscoelastic Devices (OVD), Dispersive Ophthalmic Viscoelastic Devices (OVD)), By Application (Cataract Surgery, Gl...

The Global Ophthalmic Viscoelastic Device (OVD) Market was valued at USD 1.2 billion in 2023 and is projected to reach USD 2.1 billion by 2031, growing at a CAGR of 7.2% during the forecast period of 2023-2031. The market is primarily driven by the increasing prevalence of ophthalmic disorders, growing demand for cataract and refractive surgeries, and advancements in ophthalmic surgical procedures.

Ophthalmic viscoelastic devices (OVDs) are essential in various eye surgeries, particularly cataract surgery, as they help maintain anterior chamber depth, protect corneal endothelium, and facilitate intraocular lens implantation. The rise in aging populations, technological innovations, and increasing awareness about eye care are further contributing to the market's expansion.

Market Drivers

Growing Prevalence of Eye Disorders

The rising incidence of eye diseases such as cataracts, glaucoma, and diabetic retinopathy is driving the demand for OVDs. Cataract surgeries, in particular, account for a significant portion of OVD usage, as they provide the necessary lubrication and protection during procedures.

Technological Advancements in Ophthalmic Surgeries

The introduction of new-generation OVDs, including dispersive and cohesive variants with enhanced properties, is revolutionizing ophthalmic procedures. Innovations in biocompatibility, viscosity control, and intraocular lens implantation are improving surgical outcomes.

Aging Population Driving Demand for Cataract Surgeries

As the global population ages, the number of people diagnosed with age-related eye diseases is increasing. Cataract surgeries remain one of the most common surgical procedures worldwide, significantly boosting the demand for OVDs.

Rising Healthcare Expenditure and Medical Tourism

Many countries are investing in ophthalmic healthcare infrastructure, making advanced eye surgeries more accessible. Additionally, medical tourism in ophthalmology, especially in regions like Asia-Pacific, is expanding the market by attracting international patients seeking cost-effective yet high-quality eye care services.

Market Restraints

High Cost of Premium OVDs

Although standard OVDs are widely used, premium and highly specialized OVDs can be costly. This may limit their adoption in developing countries where affordability is a concern.

Stringent Regulatory Approvals

Regulatory challenges and approval requirements for ophthalmic viscoelastic devices vary across regions. Obtaining FDA, CE Mark, and other regulatory approvals can delay product launches and increase costs for manufacturers.

Limited Awareness in Developing Regions

Despite technological advancements, awareness regarding the benefits of OVDs in ophthalmic procedures remains limited in low-income and rural areas, restricting market penetration.

Market Opportunities

Increasing Adoption of Advanced Surgical Techniques

Minimally invasive surgeries such as phacoemulsification and femtosecond laser-assisted cataract surgery (FLACS) are gaining traction, boosting demand for high-quality viscoelastic solutions.

Growth in Emerging Markets

Developing regions such as Asia-Pacific and Latin America present lucrative opportunities due to increasing healthcare investments, improving medical infrastructure, and government initiatives promoting eye health.

R&D Investments in Next-Generation OVDs

Key players are investing in next-generation viscoelastic materials with improved safety, higher retention, and enhanced endothelial cell protection, paving the way for sustained market growth.

Market by Type Insights

The Cohesive OVDs segment dominated the market in 2023, accounting for the largest market share. Cohesive OVDs are preferred for their higher molecular weight, superior chamber maintenance properties, and ease of removal after surgery.

However, Dispersive OVDs are expected to witness the highest growth rate due to their protective nature, which prevents corneal damage during complex surgical procedures.

Market by Application Insights

Cataract Surgery (Largest Segment)

Cataract surgery remains the largest application segment, contributing to over 65% of the total market share. The high volume of cataract procedures globally and the essential role of OVDs in these surgeries drive segment dominance.

Glaucoma Surgery

The use of OVDs in glaucoma filtration surgery is growing, particularly with the rise in minimally invasive glaucoma surgery (MIGS).

Corneal Transplantation & Vitreoretinal Surgeries

OVDs play a critical role in corneal transplantation and vitreoretinal surgeries, helping maintain anterior chamber integrity and facilitating better surgical outcomes.

Market by Regional Insights

North America (Largest Market)

Dominated the market in 2023 due to a high number of cataract surgeries, strong healthcare infrastructure, and a large aging population.

Presence of leading market players and advanced reimbursement policies further drive market growth.

Asia-Pacific (Fastest Growing Market)

Expected to witness the highest growth rate due to rising demand for cataract surgeries, expanding healthcare facilities, and growing medical tourism.

China, India, and Japan are emerging as key contributors to regional market growth.

Europe

Holds a significant share due to strong government support for ophthalmic research and a high adoption rate of advanced surgical techniques.

Latin America & Middle East & Africa

Gradual market expansion due to increasing awareness, growing investment in eye care, and government initiatives for blindness prevention programs.

Competitive Scenario

Key players in the Global Ophthalmic Viscoelastic Device (OVD) Market include:

Alcon, Inc.

Johnson & Johnson Vision

Bausch + Lomb

Carl Zeiss Meditec AG

Hoya Corporation

Rayner Surgical Group

BVI Medical

Abbott Medical Optics

CIMA Technology, Inc.

Haohai Biological Technology

These companies focus on product innovations, strategic partnerships, and geographic expansion to strengthen their market position.

Key Market Developments

2023: Alcon launched an advanced viscoelastic solution with improved dispersive properties for cataract surgery.

2024: Johnson & Johnson Vision partnered with leading research institutes to develop next-generation biocompatible OVDs.

2025: Bausch + Lomb announced the expansion of its ophthalmic surgery division, focusing on emerging markets.

Scope of Work – Global Ophthalmic Viscoelastic Device (OVD) Market

Key Market Developments Technological advancements in OVD formulations, increased adoption of laser-assisted surgeries

Frequently Asked Questions (FAQs)

1. What is the current market size of the Global Ophthalmic Viscoelastic Device (OVD) Market?

The market was valued at USD 1.2 billion in 2023.

2. What is the major growth driver of the OVD market?

The rising prevalence of eye disorders, particularly cataracts, is a major growth driver.

3. Which is the largest region during the forecast period?

North America dominates the market due to its advanced healthcare infrastructure and high cataract surgery rates.

4. Which segment accounted for the largest market share?

The Cataract Surgery segment holds the largest share, as OVDs are critical in these procedures.

5. Who are the key market players?

Major companies include Alcon, Johnson & Johnson Vision, Bausch + Lomb, Carl Zeiss Meditec, and Hoya Corporation.

This structured and detailed market report provides accurate, SEO-friendly insights, making it ideal for business decisions in the ophthalmic industry. 🚀